A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations1-Reference-Cited by-同舟云学术

A rational dosing algorithm for basiliximab (Simulect) in pediatric renal transplantation based on pharmacokinetic-dynamic evaluations1

Published:2002-10 Issue:7 Volume:74 Page:966-971
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Kovarik John M.,Offner Gisela,Broyer Michel,Niaudet Patrick,Loirat Chantal,Mentser Mark,Lemire Jacques,Crocker John F. S.,Cochat Pierre,Clark Godfrey,Gerbeau Christophe,Chodoff Lawrence,Korn Alexander,Hall Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference12 articles.

1. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

2. REDUCTION OF THE OCCURRENCE OF ACUTE CELLULAR REJECTION AMONG RENAL ALLOGRAFT RECIPIENTS TREATED WITH BASILIXIMAB, A CHIMERIC ANTI-INTERLEUKIN-2-RECEPTOR MONOCLONAL ANTIBODY1,2

3. Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation

4. REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1

5. POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS FOR BASILIXIMAB IN KIDNEY TRANSPLANTATION

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Simple Method for the Prediction of Therapeutic Proteins (Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins) for First-in-Pediatric Dose Selection: Application of Salisbury Rule;Antibodies;2022-10-21

2. Standard induction with basiliximab versus no induction in low immunological risk kidney transplant recipients: study protocol for a randomized controlled trial;Trials;2021-06-24

3. Prediction of Clearance of Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins in Children: Application of Allometric Scaling;Antibodies;2020-08-05

4. Development and Application of a Physiologically-Based Pharmacokinetic Model to Predict the Pharmacokinetics of Therapeutic Proteins from Full-term Neonates to Adolescents;The AAPS Journal;2020-05-24

5. Understanding Inter-Individual Variability in Monoclonal Antibody Disposition;Antibodies;2019-12-04